Skip to main content

From Delay to Damage: Changing the EGPA Trajectory With Early Diagnosis and Biologic Therapy

Page 1

PROGRAM SLIDES

SUGGESTED READING

CLINICAL GUIDELINES

CLINICAL RESOURCES

PATIENT RESOURCES

RESOURCE

DOWNLOADS

This symposium is sponsored by Integritas Communications and supported by an educational grant from AstraZeneca. This is not an official program of the American College of Rheumatology.

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: and more. Sign up and create your flipbook.
From Delay to Damage: Changing the EGPA Trajectory With Early Diagnosis and Biologic Therapy by Integritas Communications - Issuu